Global Health

The Chugai Group upholds its mission “Dedicate ourselves to adding value by creating and delivering innovative products and services for the medical community and human health around the world.”
To fulfill this mission, Chugai considers it a duty to contribute to global health by continuously creating new products for unmet medical needs, and working on the improvement of access to healthcare.

Chugai’s Basic Approach to Global Health

1. Basic Approach

There are still many people around the world who suffer from cureless diseases, or even in cases where treatments exist, being denied access, because of poverty, institutional reasons, etc.
The Sustainable Development Goals (SDGs) included in “2030 Agenda for Sustainable Development” adopted by United Nations in 2015, stipulates “Ensure healthy lives and promote the well-being for all at all ages” as one of its goals.
To work on this goal, Chugai aims to create corporate value and contribute to addressing social issues, by creating and supplying new products and cooperating with public institutions, NGOs, industry associations, etc., in view of improving access to healthcare which is an issue of global health.

2. Priorities in Addressing Global Health

2.1 Developing New Products for Diseases with no Treatments

Chugai will create and develop new products for unmet medical needs, such as treatment of cureless diseases, using its drug discovery technology centered on bio-technologies, obtained through its research and development.

2.2 Improving Quality of Healthcare and Access to Pharmaceuticals

Chugai will work on building skills of medical staff in terms of prevention, diagnosis and treatment, as well as disseminating healthcare knowledge to rural residents, as its basic approach to improving quality of healthcare.
In addition, it will work towards removing barriers preventing access to pharmaceuticals in the low- and middle- income countries.
Through these actions, Chugai will contribute to improving healthcare system as well as access to pharmaceuticals on a sustainable basis.

3. Points Considered for Individual Activities

Chugai will consider the following points in implementing or supporting individual activities of global health.

  • Whether it will utilize Chugai’s strength or specialty
  • Whether it will contribute to sustainable improvement of healthcare, mainly in low- and middle- income countries

Specific Initiative to Global Health

Participation in Global Health Innovative Technology Fund(GHIT Fund)

News Releases: Participation in the Global Health Innovative Technology Fund (GHIT Fund) (Dec 24, 2014) [PDF 120KB]

GHIT Fund is a public-private partnership to support research and development of pharmaceuticals, vaccines and diagnostics for serious diseases in developing countries. It utilizes Japan’s medical technology, innovation and knowledge more directly. (https://www.ghitfund.org/)

Participation in Access Accelerated

News Releases: Chugai to Join Global Initiative for Addressing Rise of Non-Communicable Diseases in Low and Lower-Middle Income Countries (Jan 18, 2017)

To work on the United Nations Sustainable Development Goal to reduce premature deaths from NCDs by one-third by 2030, 22 leading biopharmaceutical companies launched Access Accelerated. It’s a global initiative to advance access to non-communicable disease(NCD) prevention and care in low and middle income countries(https://accessaccelerated.org/)

Participation in WFH (World Federation of Hemophilia) Humanitarian Aid Program

WFH Humanitarian Aid Program is a landmark initiative leading the effort to change the lack of access to care and treatment for people with inherited bleeding disorders in developing countries.

  • Like
  • Tweet
  • LINE it!
  • E-mail
Back to top